Roche’s Tecentriq has gained a recommendation for approval in triple-negative breast cancer from Europe’s CHMP, setting it on track for a significant new market opportunity. The nod from the European ...

The US Food and Drug Administration (FDA) has approved the over-the-counter (OTC), non-prescription use of Harm Reduction Therapeutics’s RiVive, a 3mg naloxone hydrochloride nasal spray, for the ...

AstraZeneca’s BTK inhibitor Calquence has won approval in the US for the treatment of chronic lymphocytic leukaemia (CLL) and small lymphocytic lymphoma (SLL), taking the fight to AbbVie/Johnson & ...

Imagine the scenario where your after-dinner nap gets interrupted by your favourite iPhone ringtone just to hear the pre-recorded voice of Scarlett Johansson (did I mention the movie ‘Her’ is one of ...

The Cardiff site is one of up to 30 sites that will eventually open across the UK as part of the trial The Welsh site is one of up to 30 other sites set to open around the UK. Estimated to affect over ...

The US government has announced the ten drugs selected for the first round of pricing negotiations under President Biden’s Inflation Reduction Act (IRA). The IRA allows Medicare, the government health ...

Astellas Pharma and Cullgen have announced a research collaboration and exclusive option agreement aimed at advancing targeted protein degraders, with the deal potentially worth up to $1.9bn. Protein ...

German biotech company CureVac is planning to expand the protocols for its ongoing late-stage trials of its COVID-19 vaccine candidate CVnCoV to determine if the jab is effective against new virus ...

Novo Nordisk and Echosens, a high-technology company specialising in liver diagnostics, have collaborated to advance early diagnosis of non-alcoholic steatohepatitis (NASH). The partnership aims to ...

The US health department has proposed three new models to help lower the cost of drugs, promote accessibility and improve quality of care for those enrolled in voluntary government health insurance ...

Researchers have published some promising results for a new gene therapy method that may offer hope for children born with the ultra-rare genetic disease aromatic amino acid decarboxylase (AADC) ...

Biogen’s oral multiple sclerosis product Tecfidera has been a massive earner for the company, but is facing challenges to its patents. The company’s now filed a follow-up in the US to try to defend ...